Investor Sandler Capital Management
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Sandler Capital Management . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2020-02-12 13G/A BLFS / BioLife Solutions, Inc. 968,073 567,768
2019-02-14 13G/A BLFS / BioLife Solutions, Inc. 769,040 968,073
2018-07-20 13G BLFS / BioLife Solutions, Inc. 769,040
2013-10-01 13D/A
2013-08-14 13D/A 682,555
2013-07-26 13D/A 808,706
2013-07-12 13D/A 938,669
2012-03-14 13D/A 1,040,289